(Stroke. 2000;31:1935.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology (C.G.-G., C.T.-F., R.W., F.W., T.B.) and the Department of Dermatology (I.W., I.H.), University of Heidelberg, Heidelberg, Germany.
Correspondence to Dr C. Grond-Ginsbach, Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany. E-mail Caspar Grond-Ginsbach{at}med.uni-heidelberg.de
| Abstract |
|---|
|
|
|---|
MethodsWe studied the gene encoding tropoelastin (ELN) by reverse transcriptionpolymerase chain reaction and subsequent sequence analysis in 10 patients with abnormalities in their elastic fibers.
ResultsNo mutations were found in the whole coding region of the ELN gene. The simultaneous visualization and quantification of ELN splice variants by gene scanning enabled the analysis of the regulation of alternative splicing of ELN mRNA. No differences could be detected between fibroblast cultures of the patients and a control subject.
ConclusionsNeither mutations in the ELN gene nor dysregulation of its activity appears to be the cause of the connective tissue disorder that is found in most patients with spontaneous dissections.
Key Words: dissections RNA splicing, alternative sequence analysis tropoelastin
| Introduction |
|---|
|
|
|---|
Elastic fibers are complex structures, composed of microfibrils and amorphous material. Fibrillin and various microfibril-associated proteins are found in the fibrillar part, whereas the amorphous part of the elastic fibrils consists mainly of elastin, a cross-linked form of posttranslationally modified tropoelastin.4 Several pathological conditions (supravalvular aortic stenosis, cutis laxa, and moyamoya disease) have been correlated with mutations in the gene encoding tropoelastin (ELN)5 6 7 8 or with dysregulation of ELN gene activity.9
In the present study, we investigate by direct sequence analysis the coding region of the ELN gene in sCAD patients with moderate to severe alterations in the morphology of the elastic fibers. Fibroblast cultures from 10 patients were analyzed. The pattern of alternative splicing of the ELN mRNA of the patients was also compared with ELN mRNA from a healthy control person.
| Subjects and Methods |
|---|
|
|
|---|
Skin biopsies were taken from the outer side of the upper arm by open deep-knife biopsy. Part of the material was processed for electron microscopy according to Anton-Lamprecht.10 From another part of the biopsy, fibroblasts were cultured in MEM supplied with 10% FCS according to standard procedures.
RNA was prepared from cultured skin fibroblasts with RNA-zol (AGS-Heidelberg), and cDNA was synthesized with muLV Reverse Transcriptase and random hexamers (Perkin-Elmer). A mixture of deaza-dGTP and dGTP (3:1) was used for the first-strand cDNA synthesis. The whole coding sequence of the ELN cDNA was amplified by use of synergy Taq with proofreading activity from Natutec in a 20 µL volume in the presence of 7% dimethyl sulfoxide by nested polymerase chain reaction (PCR) in overlapping fragments. To each amplification, 0.5 µL cDNA was added, which corresponds to an initial 10 to 25 ng mRNA. After 22 cycles of amplification, the DNA was diluted 1:100. One microliter was amplified with a set of nested primer for another 22 cycles. After an initial denaturation for 1 minute at 94°C, the denaturation in each round of amplification was reduced to 5 seconds; annealing lasted 15 seconds at a temperature that was 5°C lower than the temperature of the primers. Primer extension was performed at 68°C for a duration of 1 minute for 1000 bp.
PCR primers were named according to their position on the sequence M36860 by Fazio et al,11 except for primer 18855 (3' untranslated region), which was designed on the basis of the sequence U63721,12 and +99 (exon 26A), which was designed on the basis of the sequence U93037.5 Forward primers are as follows: 00006 (ATAAAACGAGGTGCGGAG), 00027 (GGGCTGGGGCATTTCT), 00453 (GAGTGAAGCCTGGGAAAGT), 00926 (TGGAGGCATCGCAGGCGTTGGGACT), 00998 (GGAGCTGCTGCAGGCTTAGT), 01240 (CGGGGTTGGAGCTGGGGGCTTTCC), 01295FAM (GGAGTCGCAGGTGTCCCTAGTG), 01891 (CTCTCGGTGGAGTAGGCATCCCAG), and +099 (CCCTGAGCTCAGGGAAGGAGA). Reverse primers are as follows: 10571 (TGGAGCCTTGGGCTTAACTC), 10992 (ACTAAGCCTGCAGCAGCTCC), 11354 (CCTCCGACTCCGACACCAAAGCC), 11918 (CGGCGGGTCCGGCTCCCACCTCT), 12205 (TCTCTTCCGGCCACAAGCTTT), and 18855 (TAGCACCAACGTTGATGAGGTCGTG).
All amplification products were inspected after electrophoresis on a 2% agarose gel stained with ethidium bromide. FAM-labeled amplicons, synthesized with the primers 01295FAM and 12205, were run in POP-4 gel matrix (PE Biosystems) on a genetic analyzer (ABI Prism 310) and analyzed with Gene Scan software. A GS-1000-ROX molecular weight marker (PE Biosystems) was added to each separate run. The whole coding region of the ELN gene was amplified in a half-nested 2-step procedure with primers 00006 and 12205, followed by a second amplification with primers 00027 and 12205. The amplified DNA was cloned in a pCRII-TOPO vector (Invitrogen BV), single clones were picked, and the DNA was directly reamplified with M13 primers.
PCR products were prepared for dye terminator cycle sequence analysis (Perkin-Elmer) and analyzed by the ABI Prism 310 genetic analyzer according to the manufacturers instructions.
| Results |
|---|
|
|
|---|
|
|
Alternative Splicing of ELN mRNA in Cultured Fibroblasts
We established fibroblast cultures from dermal biopsies of
patients and a control person and analyzed the coding
region of the ELN gene by reverse transcription PCR. After reverse
transcription of total RNA from cultured fibroblasts, the whole coding
region of the ELN gene was amplified in 4 overlapping fragments. Three
of these amplified fragments were processed directly for cycle
sequencing analyses. However, the 3' end of the cDNA is
alternatively spliced, and various fragments of different length are
produced by PCR. In cultured dermal fibroblasts, we observed 2 major
cDNA variants of different length (peaks B and D in Figure 2
). After cloning and sequencing of the
PCR fragments, these were interpreted as different splice variants.
Exons 22, 24A, and 26A were never found in 20 analyzed clones
from region 0027 up to region 2236 of the ELN cDNA, encompassing the
whole coding region. Exons 23, 32, and 33 were absent in some of the
messengers because of alternative splicing. Major splice products
can be visualized and quantified by gene scanning of regions 1295
through 2236 of the cDNA: the full-length mRNA (E, 9.7%), the
mRNA without exon 32 (D, 42.0%), the mRNA without exons 32 and 33 (C,
3.3%), the mRNA without exons 32 and 23 (B, 34.8%), and the mRNA
without exons 23, 32, and 33 (A, 4.2%). These 5 splice variants
encompass
95% of the total amount of amplified ELN cDNA. However,
various other splice variants are seen as small peaks in Figure 2
. Moreover, with the aid of a PCR primer that anneals in exon
26A (an exon that is known to be rarely expressed), a product was
generated in the cDNA samples of most patients (data not shown). Hence,
an even higher number of splice variants of the ELN transcript is
produced in at least some patients. The overall pattern of splice
variants in cultured fibroblasts of different patients and of the
control subject is similar (Figure 2
, A through D).
|
Sequence Analysis of the Coding Region of the ELN
mRNA
PCR fragments were cycle-sequenced in both directions. The
obtained results were compared with the published consensus
sequence.11 No mutation was detected in any of the
patients. Not analyzed were the sequences of exon 22, exon 24A,
and exon 26A, because we never or rarely found these sequences
expressed in our cDNA.
| Discussion |
|---|
|
|
|---|
For the present study, we selected sCAD patients without signs of a known connective tissue disorder and with strong morphological alterations of the dermal elastic fibers. In this subset of patients, we found 3 patients with recurrent dissections. Moreover, 1 of them had a first-degree relative (father) with a dissection too. The patients in the present study were selected according to such restrictive criteria that the falsification of our hypothesis of possible mutations in the ELN gene in patients with sCAD seems to be definite. It is remarkable that no female patients were found in this sample. It has been observed in a large series of patients with sCAD (T. Brandt, E. Orberk, R. Weber, unpublished data) that morphological connective tissue alterations are found more frequently in male sCAD patients than in female sCAD patients. Moreover, in the sample of female sCAD patients with morphological connective tissue aberrations, these aberrations are generally of a somewhat milder degree than those found in male patients.
The ELN gene was examined in the present study on the basis of RNA from cultured fibroblasts. This enabled both the rapid sequence analysis of large parts of the coding regions and the analysis of various splice products. However, the regulation of the transcriptional activity and of alternative splicing is known to be tissue specific. The expression of the ELN gene in cultured fibroblasts might differ substantially from the in vivo situation in the dermal connective tissue or in the tissues at risk (the vessel walls of the arteria carotis and arteria vertebralis).
Our investigation of the coding region of the ELN gene did not explain the observations made in dermal biopsies of patients with spontaneous cervical artery dissections. The cause for the abnormal morphology of the elastic fibers remains unclear. Either some other structural components of the elastic fiber or some of the many factors that regulate its biosynthesis might be defective, or the abnormal morphology of the elastic fiber is secondary.
Until now, the search for mutations in sCAD patients was not successful. However, an autosomal dominant inheritance of an ultrastructural connective tissue disorder was recently demonstrated in some families of patients with sCAD.16 The study of such pedigrees might enable the identification of further candidate genes that are involved in the pathogenesis of this disease.
| Acknowledgments |
|---|
Received December 6, 1999; revision received April 18, 2000; accepted April 18, 2000.
| References |
|---|
|
|
|---|
2. Brandt T, Hausser I, Orberk E, Grau A, Hartschuh W, Anton-Lamprecht I, Hacke W. Ultrastructural connective tissue abnormalities in patients with spontaneous cervico-cerebral artery dissections. Ann Neurol. 1998;44:281285.[Medline] [Order article via Infotrieve]
3.
Schievink WI, Wijdicks EFM, Michels VV, Vockley J,
Godfrey M. Heritable connective tissue disorders in cervical artery
dissections: a prospective study. Neurology. 1998;50:11661169.
4. Indik Z, Yeh H, Ornstein-Goldstein N, Kucich U, Abrams W, Rosenbloom JC, Rosenbloom J. Structure of the elastin gene and alternative splicing of elastin mRNA: implications for human disease. Am J Med Genet. 1989;34:8190.[Medline] [Order article via Infotrieve]
5.
Li DY, Toland AE, Boak BB, Atkinson DL, Ensing
GJ, Morris CA, Keating MT. Elastin point mutations cause an obstructive
vascular disease, supravalvular aortic stenosis.
Hum Mol Genet. 1997;6:10211028.
6. Li DY, Faury G, Taylor DG, Davis EC, Boyle WA, Mecham RP, Stenzel P, Boak B, Keating MT. Novel arterial pathology in mice and humans hemizygous for elastin. J Clin Invest. 1998 15;102:17831787.
7.
Tassabehji M, Metcalfe K, Hurst J, Ashcroft GS, Kielty
C, Wilmot C, Donnai D, Read AP, Jones CJP. An elastin gene mutation
producing abnormal tropoelastin and abnormal elastic fibres in a
patient with autosomal dominant cutis laxa. Hum Mol Genet. 1998;7:10211028.
8. Zhang MC, He L, Giro M, Yong SL, Tiller GE, Davidson JM. Cutis laxa arising from frameshift mutations in exon 30 of the elastin gene (ELN). J Biol Chem. 1999;8:274:981986.
9.
Yamamoto M, Aoyagi M, Tajima S, Wachi H, Fukai N,
Matsushima Y, Yamamoto K. Increase in elastin gene expression and
protein synthesis in arterial smooth muscle cells derived
from patients with moyamoya disease. Stroke. 1997;28:17331738.
10. Anton-Lamprecht I. The skin. In: Papadimitriou JM, Henderson DW, Spagnolo DV, eds. Diagnostic Ultrastructure of Non-Neoplastic Diseases. Edinburgh, UK: Churchill Livingstone; 1992:90109.
11. Fazio MJ, Olsen DR, Kauh EA, Baldwin CT, Indik Z, Ornstein-Goldstein N, Yeh H, Rosenbloom J, Uitto J. Cloning of full-length elastin cDNAs from a human skin fibroblast recombinant cDNA library: further elucidation of alternative splicing utilizing exon-specific oligonucleotides. J Invest Dermatol. 1988;91:458464.[Medline] [Order article via Infotrieve]
12. Osborne LR, Martindale DW, Scherer SW, Shi X-M, Huizenga J, Heng HHQ, Costa T, Pober B, Lew L, Brinkman J, Rommens J, Koop BF, Tsui L-C. Identification of genes from a 500-kb region at 7q11.23 that is commonly deleted in Williams syndrome patients. Genomics. 1996;36:328336.[Medline] [Order article via Infotrieve]
13.
Kuivaniemi H, Prockop DJ, Wu Y, Madhatheri SL, Kleinert
C, Earley JJ, Jokinen A, Stolle C, Majamaa K, Myllyla VV, Norrgard O,
Schievink WI, Mokri B, Fukawa O, ter Berg JWM, De Paepe A, Lozano AM,
Leblanc R, Ryynanen M, Baxter BT, Shikata H, Ferell RE, Tromp G.
Exclusion of mutations in the gene for type III collagen (COL3A1) as a
common cause of intracranial aneurysms or cervical artery
dissections: results from sequence analysis of the coding
sequences of type III collagen from 55 unrelated patients.
Neurology. 1993;43:26522658.
14. van den Berg JS, Limburg M, Kappelle LJ, Pals G, Arwert F, Westerveld A. The role of type III collagen in spontaneous cervical arterial dissections. Ann Neurol. 1998;43:494498.[Medline] [Order article via Infotrieve]
15.
Grond-Ginsbach C, Weber R, Haas J, Orberk E, Kunz S,
Busse O, Hausser I, Brandt T, Wildemann B. Mutations in the COL5A1
coding sequence are not common in patients with spontaneous cervical
artery dissections (sCAD). Stroke. 1999;30:18871890.
16. Grond-Ginsbach C, Hausser I, Orberk E, Weber R, Wigger F, Brandt T. Familial connective tissue alterations in patients with spontaneous cervical artery dissections. Cerebrovasc Dis. 2000;10(suppl 2):37.
This article has been cited by other articles:
![]() |
S. Debette and H. S. Markus The Genetics of Cervical Artery Dissection: A Systematic Review Stroke, June 1, 2009; 40(6): e459 - e466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Arnold, C. Grond-Ginsbach, I. Hausser, T. Brandt, B. Krischek, I. Inoue, and H. Kasuya Collagen Morphology Is Not Associated With the Ala549Pro Polymorphism of the COL1A2 Gene * Response: Stroke, October 1, 2005; 36(10): 2068 - 2069. [Full Text] [PDF] |
||||
![]() |
S. M. Rubinstein, S. M. Peerdeman, M. W. van Tulder, I. Riphagen, and S. Haldeman A Systematic Review of the Risk Factors for Cervical Artery Dissection Stroke, July 1, 2005; 36(7): 1575 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Brandt, E. Orberk, R. Weber, I. Werner, O. Busse, B. T. Muller, F. Wigger, A. Grau, C. Grond-Ginsbach, and I. Hausser Pathogenesis of cervical artery dissections: Association with connective tissue abnormalities Neurology, July 10, 2001; 57(1): 24 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. I. Schievink Spontaneous Dissection of the Carotid and Vertebral Arteries N. Engl. J. Med., March 22, 2001; 344(12): 898 - 906. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |